The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.

In a breakthrough for influenza research, scientists have discovered immune cells that can recognize influenza (flu) viruses ...

SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse ...

The virus was linked with the rapid growth of plaque in the coronary arteries which increases the chances of major ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before they become widespread. This approach could significantly support public ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.